-
Innovation Ranking
NewInnovation Ranking – Hanmi Science Co Ltd
Hanmi Science Co Ltd (Hanmi Science) is a pharmaceutical company. Its research, development and commercialization of various active pharmaceutical ingredients, key intermediates, Cephalosporin APIs and cephalosporin finished dosage forms in both prescription and over-the-counter markets. Its pipeline includes efocipegtrutide, hm15912, lapsglucagon and bh3120, among others. Hanmi Science prescription includes prescription drugs including antidepressants, NSAIDs, neuropathic pain, oral care, hair growth, anti-inflammatory, osteoporosis and diabetes, among others.The company supplies its products across the world. Hanmi Science is headquartered in Hwaseong, Gyeonggi,...
-
Innovation Ranking
NewInnovation Ranking – Hanmi Pharmaceuticals Co Ltd
Hanmi Pharmaceuticals Co Ltd (Hanmi Pharmaceuticals), a subsidiary of Hanmi Science Co Ltd, develops prescription drugs and over the counter (OTC) drugs. The company’s prescription drugs include antibiotics, antidiarrheal, drugs for osteoporosis, liver supplements and antiemetics. It provides OTC products such as nutritional supplements, calcium supplement, and vitamins, among others. The products of Hanmi Pharmaceuticals are used in the treatment of cancer, depression, dementia, dermatology, diabetes, inflammation, cardiovascular conditions, epilepsy, hepatitis, osteoarthritis, gastrointestinal diseases, obesity, osteoporosis and others. The company...
-
Company Insights
Innovation and Patenting activity of Hanmi Semiconductor Co., Ltd. Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Hanmi Semiconductor Co., Ltd. Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Company Insights
Innovation and Patenting activity of Hanmi Pharmaceuticals Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Hanmi Pharmaceuticals Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BH-3120 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BH-3120 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BH-3120 in Solid Tumor Drug Details: BH-3120 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (Cisplatin + Vinblastine Sulphate) in Metastatic Hepatocellular Carcinoma (HCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Cisplatin + Vinblastine Sulphate) in Metastatic Hepatocellular Carcinoma (HCC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Cisplatin + Vinblastine Sulphate) in Metastatic Hepatocellular...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Bladder Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Bladder Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Bladder Cancer Drug Details: Cabozantinib s-malate (Cabometyx, Aptimetyx) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HCP-2102 in Idiopathic (Essential) Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HCP-2102 in Idiopathic (Essential) Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HCP-2102 in Idiopathic (Essential) Hypertension Drug Details: HCP-2102 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Venetoclax in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Venetoclax in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venetoclax in Solid Tumor Drug Details: Venetoclax (ABT-199, GDC-0199/RG7601, Venclexta, Venclyxto)...